Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India
- PMID: 25781206
- DOI: 10.1089/mdr.2014.0176
Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India
Abstract
Stenotrophomonas maltophilia is an emerging nosocomial pathogen responsible for serious human infections. This study was carried out to determine antibiotic susceptibility, resistance mechanisms (integrons, sul1 and sul2), and genetic relatedness (Enterobacterial Repetitive Intergenic Consensus [ERIC]-PCR) among 106 clinical isolates of S. maltophilia from India. Twenty-four (22.6%) of S. maltophilia isolates exhibited resistance to mainstay antibiotic trimethoprim-sulfamethoxazole (TMP-SMX). Except for 2 isolates which contained both TMP-SMX resistance determinants sul1 and sul2 genes, all other 22 TMP-SMX-resistant isolates carried either sul1 (10 isolates) or sul2 (12 isolates) genes. Class 1 integrons were present in 8.5% (9 out of 106) of S. maltophilia isolates, and only 5 out of these isolates were TMP-SMX resistant and positive for sul1 gene. The same isolates also carried resistance cassettes containing qac/smr gene. Minocycline and levofloxacin exhibited the maximum in vitro activity against S. maltophilia. ERIC-PCR revealed high diversity among S. maltophilia isolates. The present study demonstrated high (22.4%) TMP-SMX resistance in clinical isolates of S. maltophilia from India. TMP-SMX-resistant isolates carried relatively higher percentage of sul2 gene than sul1 gene as against the reported literature. Majority (58.3%) of sul1 gene positive were not associated with class 1 integrase gene.
Similar articles
-
Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.Microb Drug Resist. 2016 Dec;22(8):688-695. doi: 10.1089/mdr.2015.0306. Epub 2016 Mar 23. Microb Drug Resist. 2016. PMID: 27007167
-
[Analysis of acquired resistance genes in Stenotrophomonas maltophilia].Korean J Lab Med. 2010 Jun;30(3):295-300. doi: 10.3343/kjlm.2010.30.3.295. Korean J Lab Med. 2010. PMID: 20603591 Korean.
-
Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes.Emerg Infect Dis. 2007 Apr;13(4):559-65. doi: 10.3201/eid1304.061378. Emerg Infect Dis. 2007. PMID: 17553270 Free PMC article.
-
Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: A systematic review and meta-analysis.J Glob Antimicrob Resist. 2023 Sep;34:253-267. doi: 10.1016/j.jgar.2023.02.018. Epub 2023 Mar 9. J Glob Antimicrob Resist. 2023. PMID: 36906172
-
Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen.Pharmacotherapy. 1997 Mar-Apr;17(2):293-301. Pharmacotherapy. 1997. PMID: 9085321 Review.
Cited by
-
Risk Factors for Mortality in Hospitalized Patients with Stenotrophomonas maltophilia Bacteremia.Infect Drug Resist. 2022 Jul 21;15:3881-3886. doi: 10.2147/IDR.S371129. eCollection 2022. Infect Drug Resist. 2022. PMID: 35903579 Free PMC article.
-
Taxonogenomics reveal multiple novel genomospecies associated with clinical isolates of Stenotrophomonas maltophilia.Microb Genom. 2018 Aug;4(8):e000207. doi: 10.1099/mgen.0.000207. Epub 2018 Aug 7. Microb Genom. 2018. PMID: 30084764 Free PMC article.
-
Epidemiology and Antimicrobial Resistance of Stenotrophomonas maltophilia in China, 2014-2021.Infect Dis Ther. 2025 Jan;14(1):261-274. doi: 10.1007/s40121-024-01099-7. Epub 2024 Dec 28. Infect Dis Ther. 2025. PMID: 39731666 Free PMC article.
-
Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China.PLoS One. 2016 Jun 16;11(6):e0157693. doi: 10.1371/journal.pone.0157693. eCollection 2016. PLoS One. 2016. PMID: 27310255 Free PMC article.
-
Prevalence of antibiotic-resistant, toxic metal-tolerant and biofilm-forming bacteria in hospital surroundings.Environ Anal Health Toxicol. 2020 Sep;35(3):e2020018. doi: 10.5620/eaht.2020018. Epub 2020 Sep 28. Environ Anal Health Toxicol. 2020. PMID: 32979903 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
